Clinical trial
C-Reactive Protein as a Predictor of Stem Cell Transplant Complications
NCT00179868 · Ann & Robert H Lurie Children's Hospital of Chicago, Other · Completed
Key facts
| NCT number | NCT00179868 |
|---|---|
| Title | C-Reactive Protein as a Predictor of Stem Cell Transplant Complications |
| Official title | C-Reactive Protein As a Predictor of Major Transplant Complications in Pediatric Stem Cell Transplant Patients |
| Lead sponsor | Ann & Robert H Lurie Children's Hospital of Chicago, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Cancer, Leukemia, Stem Cell Transplantation |
| Intervention type | Behavioral |
| Interventions | C-Reactive Protein levels |
| Enrollment | 70 |
| Start date | Jan 1, 2003 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 6, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: